Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) Net Margin (2024)

Zentalis Pharmaceuticals has reported Net Margin over the past 1 years, most recently at 176.71% for Q4 2024.

  • Quarterly results put Net Margin at 176.71% for Q4 2024, changed N/A from a year ago — trailing twelve months through Sep 2025 was 555.8% (down 11339.0% YoY), and the annual figure for FY2024 was 246.0%, changed.
  • Net Margin for Q4 2024 was 176.71% at Zentalis Pharmaceuticals, down from 24.75% in the prior quarter.
  • Over the last five years, Net Margin for ZNTL hit a ceiling of 24.75% in Q1 2024 and a floor of 176.71% in Q4 2024.